Brief: Ryvu Therapeutics FY Net Loss Widens To 92.1 Mln Zlotys
13/03/2024 06:13
March 13 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* FY NET LOSS 92.1 MILLION ZLOTYS VERSUS LOSS OF 83.8
MILLION
ZLOTYS YEAR AGO
* FY OPERATING REVENUE 67.3 MILLION ZLOTYS VERSUS 68.4
MILLION
ZLOTYS YEAR AGO
* FY OPERATING LOSS OF 100.9 MILLION ZLOTYS VERSUS LOSS OF
78.4
MILLION ZLOTYS YEAR AGO
Source text for Eikon: urn:newsml:reuters.com:*:nEM88m7Fpa
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys